Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. - Wikidata - awgldk - TriplyDB

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.

http://www.wikidata.org/entity/Q37354233

about

Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics Future Perspectives of Radionanomedicine Using the Novel Micelle-Encapsulation Method for Surface Modification Multi-stimuli responsive Cu2S nanocrystals as trimodal imaging and synergistic chemo-photothermal therapy agents A review of nanoparticle functionality and toxicity on the central nervous system Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Antibacterial properties of silver nanoparticles in three different sizes and their nanocomposites with a new waterborne polyurethane.Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.More effective nanomedicines through particle design Gold nanotheranostics: photothermal therapy and imaging of Mucin 7 conjugated antibody nanoparticles for urothelial cancer.Nanotechnology and the treatment of HIV infection.Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution.Science of nanofibrous scaffold fabrication: strategies for next generation tissue-engineering scaffolds.Stimulus-responsive targeted nanomicelles for effective cancer therapy.Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.Bioceramics: from bone regeneration to cancer nanomedicine.Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives.Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences.Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.Surface modification of nonviral nanocarriers for enhanced gene delivery.Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats.Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma.Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats.Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2.The role of nanotechnology in the treatment of viral infections.Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia.Liposomes and nanotechnology in drug development: focus on oncotargets.Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage Application of Various Types of Liposomes in Drug Delivery Systems.Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.Multifunctional radionanomedicine: a novel nanoplatform for cancer imaging and therapy.Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model.The inhibitory effects of nano-Ag on voltage-gated potassium currents of hippocampal CA1 neurons.Antipsychotic nanomedicine: a successful platform for clinical use.Margination of Fluorescent Polylactic Acid-Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure.Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.

P2860

Q26860760-11C6BBE6-2C3F-451C-A24D-979C84765E1A Q27023692-BC0539FE-C1CA-41D4-A91E-F6EF50DA0F61 Q27335134-7F5E5D21-8FC6-41C2-9A7B-03855DD76D89 Q28383491-0A3C7C99-BD68-4321-B4A6-3FBFD0C5E707 Q30394681-DA11EFB5-DC01-4B3A-9C75-80781A979C97 Q33740696-D66187BF-4A83-458B-A7B1-D48D488F4C77 Q33911056-4BD789DE-5C36-4266-BCC1-D275903F7985 Q34440024-B0C072ED-A8D6-4199-94E5-CC6FB7C6AB6F Q35071594-1866A25A-0BF7-45AA-ADF0-457A153CFEF0 Q35106115-754F2289-510A-4185-ABED-37ADAE49040E Q35193543-4F2D850D-0F5F-467C-8DD4-45F591357E53 Q35943647-E7AB3DE0-77BC-4233-ABD2-1887FE41D8CB Q36461825-89CFA7C1-B729-4E99-9F22-9E983A400479 Q37385435-451DA907-5CB2-4AF1-A14F-9C01DF4AE706 Q37575475-16B650C9-CB83-40CB-A833-214373B0DDC0 Q37639557-FB0DD01D-7D5D-49F0-80C0-92FB3FF6A965 Q37739975-8A08D5AA-947E-4059-95DE-518DFA290843 Q37834336-60D28624-F58F-48F8-AD79-219E335EF658 Q37947163-9B058905-732E-48B6-BC43-8AE6AD1A7520 Q38058785-1ABF3C9C-11ED-4436-BB3D-00D704F8C6E0 Q38134133-6E5AB79C-4B75-4B48-B70B-B3079CEAA16A Q38136249-C19DDCE7-14A2-4948-B58D-4CFA1790E68F Q38172635-DE7A95E6-1023-4CC0-80F6-12A1065FE805 Q38787524-5D75CF83-0C65-4BD6-ABE9-0FEF7DF3A66A Q38830784-440825EF-DF22-4E08-A0F6-A25870DF4B11 Q38999820-664ECEA7-3E2E-420C-952B-D26370FEECF9 Q39397339-C9CC197D-9FD9-4438-9C10-82C1EB49A280 Q39673895-11354A8B-86BE-47D9-A13D-B6F03DC08EA8 Q40106774-5BA9BCB6-41FA-46B3-997E-521155A257AB Q40653136-02A07529-E056-4BF2-96CD-9B1993CD146F Q41980659-A4402B8D-197E-4727-808F-BEEEA78964A8 Q42116659-617881CC-A0C1-4273-A8E7-84237A9639F5 Q42352352-4B7BEE87-F4B6-4441-8A0F-5C66FDF62422 Q43563654-0B01E64A-1B56-48D5-B205-F32FC370D0E3 Q43594008-118A4201-0972-4240-9A0F-A802188DDCA4 Q46024994-50538E87-A9DF-4B7B-8D7E-2D708848EF39 Q48165230-CC8F2E4A-EA5F-4CE1-9102-4B567ABCFBE8 Q48453772-6756F273-0F08-4F03-A1BF-8835C6A3C2F3 Q48599421-CF2A3C09-E15A-4947-99BC-C6C138D70FD6 Q51293248-386DF4D4-39C1-41DF-A4E6-AFC4006DD36B

P2860

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.

http://www.wikidata.org/entity/Q37354233

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@en

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@nl

type

label

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@en

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@nl

prefLabel

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@en

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@nl

P1433

Q37354233-BED390C9-3C72-415D-8EF4-A65FA0506DCD

P1476

Q37354233-4CB3D128-D7CF-447A-9370-FDBEA3CB3183

P2093

Q37354233-7D83EFCB-53C6-4F6E-AE99-71FF0A54BFCA

Q37354233-B3C8D7D1-D680-41D4-AB02-E44ABAA175A7

P2860

Q37354233-003E9248-5CAF-428C-B784-403F10407B99

Q37354233-01D43E27-5BD8-4D09-9F17-E3122F3B8A83

Q37354233-07105773-3CA0-432D-8ED0-EA680460505E

Q37354233-0DFF3D86-E055-4826-AAC3-D4DDACFE0266

Q37354233-105546DB-6608-40FF-BBF1-8371E30AA64B

Q37354233-11AF606A-E586-4D9F-9181-D95617EFE69E

Q37354233-12598FA0-4B19-42BA-9563-5E81E27039E4

Q37354233-1326F128-5B80-48E7-9042-A3515AAAEE7F

Q37354233-144C8313-0C92-4B98-A4F8-37472E94C383

Q37354233-159BD30F-A831-4E2E-B702-AD7EDC9E9C5C

P304

Q37354233-826A5674-402C-4E54-8291-2E3CE5987D5C

P31

Q37354233-998D781D-5731-401C-B3D6-5C8DE5118C24

P356

Q37354233-D3C0D67B-5D70-4748-9500-FAD3CD10E6A2

P433

Q37354233-3D1AC857-272A-4A84-8DE8-37A6244F45A1

P478

Q37354233-309088C8-B4FF-4FF7-AC8C-E0C39B031AC3

P577

Q37354233-9A6C5F65-AAF6-49EE-8D8A-50FDD8D304A5

P5875

Q37354233-7F54F445-522A-457B-9AAA-6B6BF19384A0

P698

Q37354233-45751A76-E797-4212-8741-75B5186BBCD7

P921

Q37354233-BC32675A-EDA5-47F2-A2AD-099FA746B83B

P356

17435889.4.1.105

P1433

P1476

Targeted nanomedicines: effect ...... cer, AIDS and brain disorders.

@en

P2093

Madaswamy S Muthu

http://www.w3.org/2001/XMLSchema#string

Sanjay Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Recent advances with liposomes as pharmaceutical carriers

The role of mononuclear phagocytes in HTLV-III/LAV infection

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention.

Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.

Biodegradable polymeric vectors for gene delivery to human endothelial cells.

Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.

Targeted drug delivery via the folate receptor.

Nanoparticulate systems for brain delivery of drugs.

P304

105-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17435889.4.1.105

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23674891

http://www.w3.org/2001/XMLSchema#string

P698

19093899

http://www.w3.org/2001/XMLSchema#string

P921